 ... the expected duration of the subject's participation, a description of the procedures to be followed, and identification of any procedures which are experimental. (2) A description of any reasonably foreseeable risks or discomforts to the subject.  The Use of Human Biological Materials in the Development of Biomedical ... - Side 158av United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight - 1986 - 278 siderUten tilgangsbegrensning - Om denne boken
 | 1998 - 902 sider
...experi-mental; (2) A description of any reasonably foreseeable risks or discomforts to the subject; (3) A description of any benefits to the subject or...records identifying the subject will be maintained; (б) For research involving more than minimal risk, an explanation as to whether any compensation and... | |
 | 1990 - 460 sider
...experimental. (2) A description of any reasonably foreseeable risks or discomforts to the subject. (3) A description of any benefits to the subject or...records identifying the subject will be maintained and that notes the possibility that the Food and Drug Administration may inspect the records. (6) For... | |
 | 2000 - 850 sider
...experimental; (2) A description of any reasonably foreseeable risks or discomforts to the subject; (3) A description of any benefits to the subject or...records identifying the subject will be maintained; (б) For research involving more than minimal risk, an explanation as to whether any compensation and... | |
 | 2001 - 524 sider
...experimental. (2) A description of any reasonably foreseeable risks or discomforts to the subject. (3) A description of any benefits to the subject or...confidentiality of records identifying the subject will be 21 CFR Ch. i (4-1-01 Edition) maintained and that notes the possibility that the Food and Drug Administration... | |
 | 2004 - 1132 sider
...experimental; (2) A description of any reasonably foreseeable risks or discomforts to the subject; (31 A description of any benefits to the subject or to...records identifying the subject will be maintained; (61 For research involving more than minimal risk, an explanation as to whether any compensation and... | |
 | 1999 - 692 sider
...experimental; (2) A description of any reasonably foreseeable risks or discomforts to the subject; (3) A description of any benefits to the subject or...confidentiality of records identifying the subject will tie maintained; (6) For research involving more than minimal risk, an explanation as to whether any... | |
 | 1993 - 1178 sider
...experimental; (2) A description of any reasonably foreseeable risks or discomforts to the subject; (3) A description of any benefits to the subject or...describing the extent, if any, to which confidentiality of 311 40 CFR Ch. I (7-1-93 Edtton) records identifying the subject will be maintained; (6) For research... | |
 | 1998 - 668 sider
...reasonably foreseeable risks or discomforts to the subject; §46.114 Deportment of Health and Human Services (3) A description of any benefits to the subject or...might be advantageous to the subject; (5) A statement describing1 the extent, If any, to which confidentiality of records Identifying the subject will be... | |
 | 1993 - 816 sider
...experimental; (2) A description of any reasonably foreseeable risks or discomforts to the subject; (3) A description of any benefits to the subject or...procedures or courses of treatment, if any. that might be advantaiwna to the subject; (5) A statement describing the extent, if any, to which confidentiality... | |
 | 2002 - 996 sider
...experimental; (2) A description of any reasonably foreseeable risks or discomforts to the subject: (3) A description of any benefits to the subject or...procedures or courses of treatment, if any, that might be advar tageous to the subject; (5) A statement describing the ea tent, if any, to which confidentiality... | |
| |
